McCann Health taps New York consumer veteran for new global health creative director

Advertising agency word cloud image
McCann Global Health, a specialty group inside McCann Health, named Dov Zmood as its new executive creative director. (Alpha Stock Images)

The newest McCann Health creative director is a McCann consumer veteran. Dov Zmood joins the health-focused group as executive creative director of McCann Global Health from McCann New York, where he was vice president and group creative director.

Zmood worked at New York for almost a decade handling consumer brands including FujiFilm, Nespresso, U.S. Army and Choice Hotels. He takes over for John Washburn, who left the company to pursue other interests.

RELATED: McCann Health global science council tackles precision medicine communications challenges

McCann Global Health is the public health and social impact agency that's been run under McCann Health since 2013. The specialty group handles pharma global health initiatives as well as creative and strategic work for government- and community-based programs and non-government nonprofit organizations. Its clients include Johnson & Johnson, Novartis and Pfizer.

“It’s now become very much top of mind for companies that they need to be socially responsible. They have a responsibility to their consumers and to the environment in general,” Zmood said.

He said he hopes to bring more optimistic communications and messaging to the category versus what has been the more traditional kind of finger-wagging or scare tactics used to push people to take action for the good of their community or personal health.

RELATED: Pharma, consumer-style? New McCann Health CCO aims to inject fresh attitude

The group is excited for Zmood’s leadership, both in moving in a new direction away from telling people what to do but also for the kind of creativity he can bring to global public health, Briana Ferrigno, president of McCann Global Health, said.

“In much the way that brands are appealing to consumers throughout the world as clever and smart in educating and entertaining ways, there’s a real need to bring that energy to the global public health space,” she said.

Suggested Articles

Mylan recalls one lot of the injectable antibiotic daptomycin after discovering particles in a single-dose vial.

AbbVie's Allergan received a positive early ruling in its long-running trade secrets dispute with Evolus over a competitor to blockbuster Botox.

As Amgen ramps up clinical trials of its psoriasis drug Otezla in COVID-19, it might also be studying its blockbuster Enbrel in fighting the virus.